Graeme Brookes

Chief Executive Officer at Reapplix A/S

Health Technology

Distribution Services

Profile

Graeme Brookes is currently the Chief Executive Officer at Reapplix A since 2014.
Prior to this, he was the Chief Executive Officer at The Acrobot Co. Ltd.

Graeme Brookes active positions

Companies	Position	Start
Reapplix A/S Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark.	Chief Executive Officer	12/09/2014

All active positions of Graeme Brookes

Former positions of Graeme Brookes

Companies	Position	End
The Acrobot Co. Ltd. The Acrobot Co. Ltd. Medical SpecialtiesHealth Technology The Acrobot Co. Ltd. develops precision surgical systems for minimally invasive, bone conserving and orthopedic surgery. It also assists surgeons in achieving better patient outcomes by improving surgical precision and reducing surgical errors. The company was founded by Brian Davies and Justin Cobb in 1999 and is headquartered in London, GB.	President	06/12/2012

See the detail of Graeme Brookes's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Graeme Brookes's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
The Acrobot Co. Ltd. The Acrobot Co. Ltd. Medical SpecialtiesHealth Technology The Acrobot Co. Ltd. develops precision surgical systems for minimally invasive, bone conserving and orthopedic surgery. It also assists surgeons in achieving better patient outcomes by improving surgical precision and reducing surgical errors. The company was founded by Brian Davies and Justin Cobb in 1999 and is headquartered in London, GB.	Health Technology
Reapplix A/S Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark.	Distribution Services